Annexon, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Annexon, Inc. (ANNX) on November 12, 2025, with the report date updated to November 14, 2025, following the closing of a public offering. The Company, incorporated in Delaware and headquartered in Brisbane, California, is an emerging growth company trading on The Nasdaq Stock Market.
Key Financial Metrics and Transaction Details
The filing details a significant capital raise through the issuance of common stock and pre-funded warrants. Key transaction metrics include:
- Shares Issued: 25,096,153 shares of Common Stock at $2.60 per share.
- Pre-Funded Warrants: 3,750,000 warrants to purchase Common Stock at $2.599 per warrant.
- Over-Allotment Option: Underwriters exercised their option in full on November 13, 2025, to purchase an additional 4,326,922 shares.
- Net Proceeds: Approximately $80.4 million after deducting underwriting discounts, commissions, and estimated offering expenses.
- Closing Date: November 14, 2025.
The filing does not provide specific data on revenue, profit, operating cash flow, margins, or existing debt levels, as this report focuses solely on the entry into a material definitive agreement and the offering event.
Material Changes and Offering Structure
The primary material change is the increase in outstanding share count and the influx of liquidity from the Offering. The Pre-Funded Warrants are exercisable immediately but are subject to beneficial ownership limitations (9.99% cap, extendable to 19.99% with 61 days' notice). The underwriters for the transaction were Goldman Sachs & Co. LLC, TD Securities (USA) LLC, and Wells Fargo Securities, LLC.
Guidance, Risks, and Forward-Looking Statements
The filing contains forward-looking statements regarding the expected net proceeds and the anticipated closing date, which are subject to uncertainties. The Company disclaims any obligation to update these statements. Risks associated with the offering and the Company's business are referenced in its Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent Quarterly Reports on Form 10-Q. No specific operational guidance or management commentary on future performance was included in this specific filing.
Investor Verification Checklist
- Verify the final number of shares outstanding post-offering to assess dilution impact.
- Confirm the exact use of the $80.4 million in net proceeds as detailed in the related press releases (Exhibits 99.1 and 99.2).
- Review the Company's most recent Form 10-Q (September 30, 2025) for current cash position and burn rate relative to the new proceeds.
- Check for any subsequent filings regarding the exercise of pre-funded warrants by major institutional holders.